Michael A. Margolis
Corporate Officer/Principal chez OPY ACQUISITION CORP. I
Profil
Michael A.
Margolis is a Senior Managing Director at Oppenheimer & Co., Inc. and a Special Advisor at OPY Acquisition Corp.
I.
He previously worked as a Managing Director at Merriman Holdings, Inc., Director-Global Business Development at Novartis Pharmaceuticals Corp., and Head-Healthcare Investment Banking at ROTH Capital Partners LLC.
Margolis holds an MBA from The Leonard N Stern School of Business and an undergraduate degree from Ernest Mario School of Pharmacy.
Postes actifs de Michael A. Margolis
| Sociétés | Poste | Début |
|---|---|---|
| OPY ACQUISITION CORP. I | Corporate Officer/Principal | - |
Oppenheimer & Co., Inc.
 Oppenheimer & Co., Inc. Investment ManagersFinance Oppenheimer & Co., Inc. provides security brokerage services. It also offers investment banking and advice to high net worth investors, individuals, businesses and institutions. The company is headquartered in New York, NY. | Corporate Officer/Principal | 01/01/2017 |
Anciens postes connus de Michael A. Margolis
| Sociétés | Poste | Fin |
|---|---|---|
| MERRIMAN HOLDINGS, INC. | Corporate Officer/Principal | - |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | - |
ROTH Capital Partners LLC
 ROTH Capital Partners LLC Investment Banks/BrokersFinance ROTH Capital Partners LLC is a broker/dealer headquartered in Newport Beach, California. The firm was founded in 2001 and is a subsidiary of CR Financial Holdings, Inc. They offer institutional sales and trading services. Their broad institutional coverage includes investors in North America, Canada, UK, Europe and other international territories. | Corporate Officer/Principal | - |
Formation de Michael A. Margolis
| The Leonard N Stern School of Business | Masters Business Admin |
| Ernest Mario School of Pharmacy | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MERRIMAN HOLDINGS, INC. | Finance |
| Entreprise privées | 4 |
|---|---|
OPY Acquisition Corp. I
 OPY Acquisition Corp. I Financial ConglomeratesFinance OPY Acquisition Corp. I is blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization or similar business combination. The company was founded July 20, 2020 and is headquartered in New York, NY. | Finance |
Oppenheimer & Co., Inc.
Oppenheimer & Co., Inc. Investment ManagersFinance Oppenheimer & Co., Inc. provides security brokerage services. It also offers investment banking and advice to high net worth investors, individuals, businesses and institutions. The company is headquartered in New York, NY. | Finance |
ROTH Capital Partners LLC
ROTH Capital Partners LLC Investment Banks/BrokersFinance ROTH Capital Partners LLC is a broker/dealer headquartered in Newport Beach, California. The firm was founded in 2001 and is a subsidiary of CR Financial Holdings, Inc. They offer institutional sales and trading services. Their broad institutional coverage includes investors in North America, Canada, UK, Europe and other international territories. | Finance |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |